PetIQ Inc (PETQ)
16.94
+0.07
(+0.41%)
USD |
NASDAQ |
May 02, 15:08
PetIQ Cash from Financing (Quarterly): -2.367M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.367M |
September 30, 2023 | -2.252M |
June 30, 2023 | -2.484M |
March 31, 2023 | -3.086M |
December 31, 2022 | -2.309M |
September 30, 2022 | -11.11M |
June 30, 2022 | -23.16M |
March 31, 2022 | 22.86M |
December 31, 2021 | 9.468M |
September 30, 2021 | -18.94M |
June 30, 2021 | 14.63M |
March 31, 2021 | 43.17M |
December 31, 2020 | -0.472M |
September 30, 2020 | -13.10M |
June 30, 2020 | 68.12M |
March 31, 2020 | 74.22M |
Date | Value |
---|---|
December 31, 2019 | -7.826M |
September 30, 2019 | 152.96M |
June 30, 2019 | -17.01M |
March 31, 2019 | 6.933M |
December 31, 2018 | 62.89M |
September 30, 2018 | -1.287M |
June 30, 2018 | -19.98M |
March 31, 2018 | 99.35M |
December 31, 2017 | -2.966M |
September 30, 2017 | 30.38M |
June 30, 2017 | -10.02M |
March 31, 2017 | 17.98M |
December 31, 2016 | -0.159M |
September 30, 2016 | -10.24M |
June 30, 2016 | 8.216M |
March 31, 2016 | 2.871M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-23.16M
Minimum
Jun 2022
152.96M
Maximum
Sep 2019
14.81M
Average
-2.309M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
Dynavax Technologies Corp | 1.776M |
Pacira BioSciences Inc | -1.779M |
Supernus Pharmaceuticals Inc | 1.092M |
Esperion Therapeutics Inc | 4.471M |
Deciphera Pharmaceuticals Inc | 0.89M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -2.842M |
Cash from Investing (Quarterly) | -2.94M |
Free Cash Flow | 52.74M |
Free Cash Flow Per Share (Quarterly) | -0.193 |
Free Cash Flow to Equity (Quarterly) | -4.882M |
Free Cash Flow to Firm (Quarterly) | 2.126M |
Free Cash Flow Yield | 10.02% |